Bilirubin Blood Test Market: Global Industry Analysis and Forecast (2023-2029)

Bilirubin Blood Test Market size was valued at US$ 1.74 Bn. in 2022 and the total revenue is expected to grow at a CAGR of 5.44% through 2023 to 2029, reaching nearly US$ 2.53 Bn.

Bilirubin Blood Test Market Overview:

The amount of bilirubin in your blood is measured by a bilirubin blood test. Bilirubin is a yellowish chemical produced by the body during the natural breakdown of red blood cells. Bilirubin is a pigment found in bile, a digestive fluid generated by your liver. The results of this test will reveal how well your liver is working. It is frequently included in a panel of tests that assess liver function. Although a modest quantity of bilirubin in the blood is acceptable, a high level could indicate liver illness. Bilirubin Blood Test MarketTo know about the Research Methodology:- Request Free Sample Report

Bilirubin Blood Test Market Dynamics:

The rise in prevalence of neonatal jaundice, rise in health-care spending, and rise in per capita income are expected to boost the bilirubin blood tests market. Neonatal jaundice is the most prevalent indication worldwide, according to a study published in the International Journal of Pediatrics, occurring in up to 60% of babies and 80% of preterm new-borns in their first week of life. The bilirubin blood tests market is expected to be driven by high demand for handheld or portable devices utilised in this test. For example, Baebies, Inc., a corporation specialising in the design and development of devices for new-born children, has created FINDER, a compact, linked testing gadget. To perform a test, the instrument requires a little sample of blood. The first assay on the FINDER launch panel has been announced by the business. It is currently being worked on. Tests for glucose-6-phosphate dehydrogenase (G6PD), total serum albumin, and albumin are included in the FINDER launch panel, making it the first near-patient, quick, and comprehensive hyperbilirubinemia diagnostic solution. Furthermore, as the prevalence of disorders such as hemolytic anaemia, hepatitis, and liver cirrhosis rises, demand for these tests is expected to rise. During the forecast period, however, the bilirubin blood tests market is expected to be constrained by a lack of awareness and skilled specialists.

Bilirubin Blood Test Market Segment Analysis:

Based on the Test Type, the market is segmented into Total Serum Bilirubin Test, Indirect or unconjugated bilirubin test, and Direct or conjugated bilirubin test. Total Serum Bilirubin Test segment is expected to hold the largest market shares of xx% by 2029. This is a blood test that evaluates the quantity of bilirubin in the body. This test determines how well your liver is functioning. It is frequently included in a panel of tests that assess liver function. Although a modest quantity of bilirubin in the blood is acceptable, a high level could indicate liver illness. The total serum bilirubin test should be performed to detect the amount of bilirubin in the total blood in order to prevent the disease. If the levels are too high, more testing and treatments will be required. Based on the End-User, the market is segmented into Paediatrics, Hospitals, and Home Care. Hospitals segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2029. This is due to the increasing number of the patients of the bilirubin blood test in the hospitals. This is the key factor that is expected to drive the growth of the hospitals segment in the global bilirubin blood test market during the forecast period.

Bilirubin Blood Test Market Regional Insights:

North America region is expected to dominate the market during the forecast period 2022-2029. North America region is expected to hold the largest market share of xx% by 2029. High birth rates and an increase in demand for neonatal jaundice testing are attributed with the region's supremacy. This is the key driver that is expected to boost the growth of the North America region in the global market during the forecast period 2022-2029. Asia Pacific region is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2029. This is due to the huge population and rising demand for bilirubin tests in the Asia Pacific.

Competitive Landscape of the Global Bilirubin Blood Test Market:

F.Hoffmann-La Roche Ltd is expected to dominate the Global Bilirubin Blood Test Market during the forecast period 2022-2029. F.Hoffmann-La Roche Ltd is expected to hold the largest market shares of xx% by 2029. Roche, or F. Hoffmann-La Roche AG, is a Swiss global healthcare corporation that operates under two divisions: pharmaceuticals and diagnostics. Roche Holding AG, the corporation's holding company, is publicly traded on the SIX Swiss Exchange. Basel is home to the company's headquarters. Its product line includes everything from blood glucose metres for diabetics to point-of-care testing equipment for doctors' offices, as well as high-throughput analysers for hospitals and commercial diagnostic laboratories. The World Health Organization Model Lists of Essential Drugs include more than thirty Roche-developed medicines.   The objective of the report is to present a comprehensive analysis of the Globalmarket to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Bilirubin Blood Test Market dynamic, structure by analyzing the market segments and project the Global Bilirubin Blood Test Market size. Clear representation of competitive analysis of key players by Test Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.

Bilirubin Blood Test Market Scope: Inquire before buying

Global Bilirubin Blood Test Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.74 Bn.
Forecast Period 2023 to 2029 CAGR: 5.44% Market Size in 2029: US $ 2.53 Bn.
Segments Covered: by Test Type Total Serum Bilirubin Test Indirect or unconjugated bilirubin test Direct or conjugated bilirubin test
by Age Group Adults Paediatrics Infants
by End User Paediatrics Hospitals Home Care

Bilirubin Blood Test Market, by Region

Global Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Key Players

1. F.Hoffmann-La Roche Ltd 2. Danaher 3. Koninklijke Philips N.V 4. Thermo Fisher scientific Inc. 5. Advanced Instruments 6. Randox Laboratories 7. Beckman Coulter 8. Reichert Technologies 9. Dragerwerk AG 10.AVI Healthcare 11.Siemens Healthineers AG

Frequently Asked Questions:

1] Which region is expected to hold the highest share in the Bilirubin Blood Test Market? Ans. North America is expected to hold the highest share in the Bilirubin Blood Test Market. 2] Who are the top key players in the Bilirubin Blood Test Market? Ans. F.Hoffmann-La Roche Ltd, Danaher, Koninklijke Philips N.V, Thermo Fisher scientific Inc., and Advanced Instruments are the top key players in the market. 3] Which segment holds the largest market share in the Bilirubin Blood Test market by 2029? Ans. Total Serum Bilirubin Test segment hold the largest market share in the market by 2029. 4] What is the market size of the Bilirubin Blood Test market by 2029? Ans. The market size of the Bilirubin Blood Test market is expected to reach US$ 2.53 Bn. by 2029. 5] What was the market size of the Bilirubin Blood Test market in 2022? Ans. The market size of the market was worth US$ 1.74 Bn. in 2022.
1. Global Bilirubin Blood Test Market: Research Methodology 2. Global Bilirubin Blood Test Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Bilirubin Blood Test Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Bilirubin Blood Test Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Bilirubin Blood Test Market Segmentation 4.1 Global Bilirubin Blood Test Market, by Test Type (2022-2029) • Total Serum Bilirubin Test • Indirect or unconjugated bilirubin test • Direct or conjugated bilirubin test 4.2 Global Bilirubin Blood Test Market, by Age Group (2022-2029) • Adults • Paediatrics • Infants 4.3 Global Bilirubin Blood Test Market, by End User (2022-2029) • Paediatrics • Hospitals • Home Care 5. North America Bilirubin Blood Test Market (2022-2029) 5.1 Global Bilirubin Blood Test Market, by Test Type (2022-2029) • Total Serum Bilirubin Test • Indirect or unconjugated bilirubin test • Direct or conjugated bilirubin test 5.2 Global Bilirubin Blood Test Market, by Age Group (2022-2029) • Adults • Paediatrics • Infants 5.3 Global Bilirubin Blood Test Market, by End User (2022-2029) • Paediatrics • Hospitals • Home Care 5.4 North America Bilirubin Blood Test Market, by Country (2022-2029) • United States • Canada • Mexico 6. Asia Pacific Bilirubin Blood Test Market (2022-2029) 5.44. Asia Pacific Bilirubin Blood Test Market, by Test Type (2022-2029) 6.2. Asia Pacific Bilirubin Blood Test Market, by Age Group (2022-2029) 6.3. Asia Pacific Bilirubin Blood Test Market, by End User (2022-2029) 6.4. Asia Pacific Bilirubin Blood Test Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Bilirubin Blood Test Market (2022-2029) 7.1 Middle East and Africa Bilirubin Blood Test Market, by Test Type (2022-2029) 7.2. Middle East and Africa Bilirubin Blood Test Market, by Age Group (2022-2029) 7.3. Middle East and Africa Bilirubin Blood Test Market, by End User (2022-2029) 7.4. Middle East and Africa Bilirubin Blood Test Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Bilirubin Blood Test Market (2022-2029) 8.1. Latin America Bilirubin Blood Test Market, by Test Type (2022-2029) 8.2. Latin America Bilirubin Blood Test Market, by Age Group (2022-2029) 8.3. Latin America Bilirubin Blood Test Market, by End User (2022-2029) 8.4. Latin America Bilirubin Blood Test Market, by Country (2022-2029) • Brazil • Argentina • Rest Of Latin America 9. European Bilirubin Blood Test Market (2022-2029) 9.1. European Bilirubin Blood Test Market, by Test Type (2022-2029) 9.2. European Bilirubin Blood Test Market, by Age Group (2022-2029) 9.3. European Bilirubin Blood Test Market, by End User (2022-2029) 9.4. European Bilirubin Blood Test Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. F.Hoffmann-La Roche Ltd 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Danaher 10.3. Koninklijke Philips N.V 10.4. Thermo Fisher scientific Inc. 10.5. Advanced Instruments 10.6. Randox Laboratories 10.7. Beckman Coulter 10.8. Reichert Technologies 10.9. Dragerwerk AG 10.10. AVI Healthcare 10.11. Siemens Healthineers AG

About This Report

Report ID 82486
Category Healthcare
Published Date July 2023
Updated Date
  • INQUIRE BEFORE BUYING